Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001200429 | SCV001371390 | uncertain significance | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | TTC7A: PM2, BP4 |
Labcorp Genetics |
RCV002560276 | SCV003456045 | uncertain significance | Multiple gastrointestinal atresias | 2022-04-17 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 166 of the TTC7A protein (p.Ser166Leu). This variant is present in population databases (rs752931401, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with TTC7A-related conditions. ClinVar contains an entry for this variant (Variation ID: 932564). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |